The US Surgical Matrices Market treaded water in Q120, up +1.6%, as the impact of COVID-19 began to be felt broadly at the end of a quarter that had initially started with good growth.
In Q120, the US Surgical Matrices Market grew +1.6% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. Allergan* maintained its lead despite the slowdown in breast augmentation and reconstruction surgeries due to COVID-19, gaining +3.4% YoY. Becton Dickinson* (BD) also had been growing well until COVID-19 slowed hernia surgeries, and, like many other companies, warned that Q220 would be far worse since the impact of COVID-19 would be felt at the beginning of the quarter.
Among the many topics covered in the comprehensive Q120 US Surgical Matrices Market Recap* are:
- Complete Market Overview with Company Revenues and Shares
- US Breast Matrices: COVID-19 Nearly Erases Growth
- US Hernia Repair Matrices Market: Modest Growth Again
- Other Q120 US Surgical Matrices Market Events
The US Surgical Matrices market grew modestly in both the Breast Reconstruction and Hernia Repair segments, with both segments experiencing good growth until surgeries began to be delayed in mid- to late March due to the impact of COVID-19. For the quarter, the Breast segment managed to grow +2.4% YoY to $
with 34.9% share of the Surgical Matrices market in Q120. The Hernia Repair segment grew less, with +1.2% YoY growth to $ and 65.1% share of the US Surgical Matrices Market in Q120...
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
